Net Profit Margin
since 2005
Beginner level
Calculation
Bristol-Myers Squibb Co., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net earnings attributable to BMS1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 13.15% | = | 100 | × | 3,439 | ÷ | 26,145 |
| Dec 31, 2018 | 21.81% | = | 100 | × | 4,920 | ÷ | 22,561 |
| Dec 31, 2017 | 4.85% | = | 100 | × | 1,007 | ÷ | 20,776 |
| Dec 31, 2016 | 22.94% | = | 100 | × | 4,457 | ÷ | 19,427 |
| Dec 31, 2015 | 9.45% | = | 100 | × | 1,565 | ÷ | 16,560 |
| Dec 31, 2014 | 12.62% | = | 100 | × | 2,004 | ÷ | 15,879 |
| Dec 31, 2013 | 15.64% | = | 100 | × | 2,563 | ÷ | 16,385 |
| Dec 31, 2012 | 11.12% | = | 100 | × | 1,960 | ÷ | 17,621 |
| Dec 31, 2011 | 17.46% | = | 100 | × | 3,709 | ÷ | 21,244 |
| Dec 31, 2010 | 15.92% | = | 100 | × | 3,102 | ÷ | 19,484 |
| Dec 31, 2009 | 56.42% | = | 100 | × | 10,612 | ÷ | 18,808 |
| Dec 31, 2008 | 25.47% | = | 100 | × | 5,247 | ÷ | 20,597 |
| Dec 31, 2007 | 11.19% | = | 100 | × | 2,165 | ÷ | 19,348 |
| Dec 31, 2006 | 8.85% | = | 100 | × | 1,585 | ÷ | 17,914 |
| Dec 31, 2005 | 15.62% | = | 100 | × | 3,000 | ÷ | 19,207 |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
1 US$ in millions
Comparison to Competitors
Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to competitors
| Bristol-Myers Squibb Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 13.15% | 11.56% | 23.69% | -32.76% | 35.32% | 40.96% | 37.27% | 24.35% | 28.28% | 18.42% | 21.01% | 31.45% | 26.91% | 28.27% | 23.96% |
| Dec 31, 2018 | 21.81% | 7.74% | 17.36% | -32.28% | 37.25% | 32.93% | 13.16% | 25.16% | 24.78% | 18.75% | 14.71% | 20.79% | 36.42% | 68.80% | 24.52% |
| Dec 31, 2017 | 4.85% | 1.74% | 18.82% | -25.88% | 9.08% | 20.69% | -0.89% | 18.03% | 26.38% | 1.70% | 5.97% | 40.55% | 20.41% | 10.59% | 16.28% |
| Dec 31, 2016 | 22.94% | 6.71% | 23.22% | 102.76% | 35.27% | 32.34% | 12.90% | 45.07% | 19.29% | 23.01% | 9.85% | 13.66% | 18.42% | -6.58% | 16.80% |
| Dec 31, 2015 | 9.45% | 21.68% | 22.50% | 25.98% | 33.13% | 32.95% | 12.07% | 56.32% | 20.79% | 21.99% | 11.25% | 14.25% | 15.50% | -53.89% | 7.11% |
| Dec 31, 2014 | 12.62% | 11.28% | 8.89% | -12.48% | 26.69% | 30.25% | 12.19% | 49.44% | 18.98% | 21.96% | 28.22% | 18.42% | 12.34% | -127.25% | 12.18% |
| Dec 31, 2013 | 15.64% | 11.79% | 21.97% | -8.65% | 27.93% | 26.87% | 20.27% | 28.46% | 8.82% | 19.40% | 10.00% | 42.65% | 20.16% | -36.72% | 11.05% |
| Dec 31, 2012 | 11.12% | 14.95% | 28.70% | 1.64% | 26.11% | 25.02% | 18.09% | 27.57% | 13.17% | 16.14% | 13.05% | 24.70% | 54.43% | -7.01% | 10.06% |
| Dec 31, 2011 | 17.46% | 12.17% | — | 5.69% | 24.08% | 24.45% | 17.90% | 34.60% | 8.21% | 14.87% | 13.05% | 14.84% | -49.74% | 2.10% | — |
| Dec 31, 2010 | 15.92% | 13.15% | — | 5.17% | 31.56% | 21.31% | 21.97% | 39.26% | 13.83% | 21.65% | 1.87% | 12.18% | -22.76% | -526.35% | — |
| Dec 31, 2009 | 56.42% | 18.68% | — | 7.95% | 32.09% | 22.16% | 19.82% | 40.74% | 10.85% | 19.82% | 47.04% | 17.27% | -17.88% | -630.27% | — |
| Dec 31, 2008 | 25.47% | 16.53% | — | 9.40% | 28.57% | 19.11% | -10.17% | 39.55% | 8.81% | 20.31% | 32.74% | 16.78% | -34.69% | -262.02% | — |
| Dec 31, 2007 | 11.19% | 13.92% | — | 5.65% | 22.12% | 20.12% | 15.85% | 43.27% | -75.89% | 17.31% | 13.54% | 16.82% | -84.46% | -196.61% | — |
| Dec 31, 2006 | 8.85% | 7.64% | — | -22.48% | 21.29% | 8.11% | 16.97% | -45.98% | 21.65% | 20.73% | 19.59% | 39.98% | -161.30% | -95.63% | — |
| Dec 31, 2005 | 15.62% | 15.10% | — | 8.40% | 30.56% | 6.63% | 13.52% | 44.99% | -28.40% | 20.61% | 21.04% | 15.76% | -144.19% | -126.43% | — |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Bristol-Myers Squibb Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 13.15% | 21.54% |
| Dec 31, 2018 | 21.81% | 18.10% |
| Dec 31, 2017 | 4.85% | 11.00% |
| Dec 31, 2016 | 22.94% | 24.52% |
| Dec 31, 2015 | 9.45% | 22.40% |
| Dec 31, 2014 | 12.62% | 20.39% |
| Dec 31, 2013 | 15.64% | 21.29% |
| Dec 31, 2012 | 11.12% | 18.41% |
| Dec 31, 2011 | 17.46% | 15.50% |
| Dec 31, 2010 | 15.92% | 15.17% |
| Dec 31, 2009 | 56.42% | 25.96% |
| Dec 31, 2008 | 25.47% | 18.67% |
| Dec 31, 2007 | 11.19% | 15.99% |
| Dec 31, 2006 | 8.85% | 20.82% |
| Dec 31, 2005 | 15.62% | 18.13% |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Industry (Health Care)
Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to industry (health care)
| Bristol-Myers Squibb Co. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 13.15% | 15.78% |
| Dec 31, 2018 | 21.81% | 13.31% |
| Dec 31, 2017 | 4.85% | 9.28% |
| Dec 31, 2016 | 22.94% | 16.45% |
| Dec 31, 2015 | 9.45% | 15.70% |
| Dec 31, 2014 | 12.62% | 15.13% |
| Dec 31, 2013 | 15.64% | 16.06% |
| Dec 31, 2012 | 11.12% | 14.04% |
| Dec 31, 2011 | 17.46% | 13.14% |
| Dec 31, 2010 | 15.92% | 12.60% |
| Dec 31, 2009 | 56.42% | 18.63% |
| Dec 31, 2008 | 25.47% | 13.81% |
| Dec 31, 2007 | 11.19% | 13.30% |
| Dec 31, 2006 | 8.85% | 15.18% |
| Dec 31, 2005 | 15.62% | 15.79% |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).